0001209191-19-023382.txt : 20190403
0001209191-19-023382.hdr.sgml : 20190403
20190403174313
ACCESSION NUMBER: 0001209191-19-023382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NIEMANN BRADLEY V.
CENTRAL INDEX KEY: 0001669839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19961
FILM NUMBER: 19730330
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orthofix Medical Inc.
CENTRAL INDEX KEY: 0000884624
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
BUSINESS PHONE: 214-937-2000
MAIL ADDRESS:
STREET 1: 3451 PLANO PARKWAY
CITY: LEWISVILLE
STATE: TX
ZIP: 75056
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOFIX INTERNATIONAL N V
DATE OF NAME CHANGE: 19970708
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-01
0
0000884624
Orthofix Medical Inc.
OFIX
0001669839
NIEMANN BRADLEY V.
3451 PLANO PKWY
LEWISVILLE
TX
75056
0
1
0
0
President of Global Spine
Common Stock
2019-04-01
4
A
0
3603
0.00
A
29755
D
Common Stock
2019-04-01
4
A
0
7402
0.00
A
37157
D
Stock Option (right to buy)
56.20
2019-04-01
4
A
0
11939
0.00
A
2029-04-01
Common Stock
11939
11939
D
Performance Share Units
0.00
2019-04-01
4
A
0
7206
0.00
A
2022-04-01
Common Stock
7206
7206
D
Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.
Represents time-based vesting restricted stock units that vest on the second anniversary of the grant date, April 1, 2019.
These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.
Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2019 to April 1, 2022. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 1, 2019, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.
/s/ Kimberley A. Elting, Chief Legal and Administrative Officer, by power of attorney
2019-04-03